Prestige Consumer Healthcare Inc
NYSE:PBH
Prestige Consumer Healthcare Inc
NYSE:PBH
Price:
70.39 USD
0.1%
Market Closed
Updated:
May 13, 2024
Prestige Consumer Healthcare Inc
Accrued Liabilities
|
Prestige Consumer Healthcare Inc
Accrued Liabilities Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Prestige Consumer Healthcare Inc
NYSE:PBH
|
Accrued Liabilities
$80m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
2%
|
CAGR 10-Years
9%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Accrued Liabilities
$28.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
8%
|
CAGR 10-Years
8%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Accrued Liabilities
$9.9B
|
CAGR 3-Years
5%
|
CAGR 5-Years
15%
|
CAGR 10-Years
13%
|
|
|
Pfizer Inc
NYSE:PFE
|
Accrued Liabilities
$2.8B
|
CAGR 3-Years
12%
|
CAGR 5-Years
6%
|
CAGR 10-Years
5%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Accrued Liabilities
$13.1B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
4%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Accrued Liabilities
$10.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
16%
|
CAGR 10-Years
16%
|
See Also
What is Prestige Consumer Healthcare Inc's Accrued Liabilities?
Accrued Liabilities
80m
USD
80m
USD
Based on the financial report for Dec 31, 2023, Prestige Consumer Healthcare Inc's Accrued Liabilities amounts to 80m USD.
What is Prestige Consumer Healthcare Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
9%
9%
Over the last year, the Accrued Liabilities growth was -7%. The average annual Accrued Liabilities growth rates for Prestige Consumer Healthcare Inc have been -5% over the past three years , 2% over the past five years , and 9% over the past ten years .
You don't have any saved screeners yet
